DoJ Claims J&J Paid Kickbacks To Pharmacy To Boost Risperdal Use In Nursing Homes

The complaint says J&J paid Omnicare rebates to intervene in physician prescribing and sought to keep "best prices" down by substituting rebate payments for the purchase of Omnicare data.